Certified Advisory Corp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-161
Closed -$58K 351
2021
Q1
$58K Buy
+161
New +$51.8K 0.02% 325
2020
Q2
$30K Buy
116
+1
+0.9% +$267 0.01% 376
2020
Q1
$26K Hold
115
0.01% 370
2019
Q4
$35K Sell
115
-8
-7% -$2.2K 0.01% 367
2019
Q3
$29K Buy
123
+1
+0.8% +$274 0.01% 406
2019
Q2
$35K Hold
122
0.01% 371
2019
Q1
$35K Buy
122
+18
+17% +$5.21K 0.01% 344
2018
Q4
$27K Buy
104
+1
+1% +$275 0.01% 362
2018
Q3
$28K Hold
103
0.01% 379
2018
Q2
$25K Buy
103
+1
+1% +$232 0.01% 382
2018
Q1
$22K Hold
102
0.01% 390
2017
Q4
$23K Buy
+102
New +$21.7K 0.02% 345

Other funds holding ELV

Certified Advisory Corp's ELV Position: Q2 2021 in Review

Certified Advisory Corp sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 161 shares — an estimated $58K sold.

Certified Advisory Corp first reported a position in ELV in Q4 2017 and held it in 12 quarters. The position peaked at $58K in Q1 2021. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • Certified Advisory Corp reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • Certified Advisory Corp sold 161 Elevance Health shares in Q2 2021, an estimated $58K.
  • Certified Advisory Corp first reported a position in Elevance Health in Q4 2017 and held it in 12 quarters.
  • Certified Advisory Corp's Elevance Health position peaked at $58K in Q1 2021.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.